You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,201 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
  • Lymphoma, Mantle Cell
  • Mantle Cell Lymphoma
  • Rituximab (R)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-09-21
Sep 21, 2021
E
Active, not recruiting
  • Multiple Myeloma
  • Rionero in Vulture, Potenza, Italy
    Irccs Crob
2022-03-24
Mar 24, 2022
C
Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Mitoxantrone Hydrochloride Liposome injection
  • +2 more
  • Beijing, Beijing, China
    Beijing Chaoyang Hospital, Capital Medical University
2022-01-16
Jan 16, 2022
S
Recruiting
  • Antibody-mediated Rejection
  • Bortezomib
  • Tehran, Iran, Islamic Republic of
    SBMU
2022-01-27
Jan 27, 2022
H
Recruiting
  • Hematological Malignancy
  • Bortezomib
  • Detroit, Michigan
    Henry Ford hospital
2021-12-23
Dec 23, 2021
P
Not yet recruiting
  • Thrombotic Thrombocytopenic Purpura, Acquired
  • Bortezomib Injection
  • Beijing, (Select), China
    Peking Union Medical College Hospital
2021-11-22
Nov 22, 2021
P
Recruiting
  • Diffuse Large B Cell Lymphoma
  • Ibrutinib and Bortezomib + R-CHOP
  • Berlin, Germany
    Charité - Universitätsmedizin Berlin, Hematology, Oncology and T
2022-02-19
Feb 19, 2022
H
Recruiting
  • Glioblastoma
  • Bortezomib and Temozolomide Phase IB
  • Bortezomib and Temozolomide Phase II
  • Bergen, Norway
  • +1 more
2021-08-24
Aug 24, 2021
N
Recruiting
  • Neoplasms
  • +2 more
  • Bortezomib plus Clofarabine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022
M
Active, not recruiting
  • Solid Tumor
  • Urethral Cancer
  • Bortezomib
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-02-21
Feb 21, 2022
P
Recruiting
  • Autoimmune Hemolytic Anemia
  • Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
  • combination of a single dose anti-CD20 antibody and bortezomib
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
2021-10-12
Oct 12, 2021
U
Completed
  • Multiple Myeloma
  • Vorinostat Velcade Dexamethasone
  • Nottingham, Nottinghamshire, United Kingdom
  • +1 more
2021-08-09
Aug 9, 2021
U
Completed
  • Hodgkin's Lymphoma
  • Lymphoma, Non-Hodgkin
  • Ann Arbor, Michigan
    University of Michgan Comprehensive Cancer Center
2021-12-03
Dec 3, 2021
H
Recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +2 more
  • Bortezomib
  • Mexico City, Mexico
    Hospital General de México "Dr. Eduardo Liceaga"
2022-01-02
Jan 2, 2022
C
Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
2022-03-23
Mar 23, 2022
N
Completed
  • Lung Diseases, Interstitial
  • +2 more
  • Bortezomib
  • +2 more
  • Chicago, Illinois
    Northwestern University
2021-08-02
Aug 2, 2021
E
Completed
  • Multiple Myeloma
  • Bortezomib
  • +3 more
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
2021-11-01
Nov 1, 2021
R
Terminated
  • Follicular Lymphoma
  • Bortezomib and Tositumomab I-131
  • Chicago, Illinois
    Rush University Medical Center
2021-10-06
Oct 6, 2021
M
Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Bortezomib
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2021-10-06
Oct 6, 2021
N
Completed
  • Chronic Myeloid Leukemia (CML)
  • +4 more
  • Bortezomib
  • NK cells
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022
U
Active, not recruiting
  • Waldenström's Macroglobulinemia
  • Dexamethasone, Rituximab, Cyclophosphamide
  • Dexamethasone, Rituximab, Cyclophosphamide, Bortezomib
  • Ulm, Germany
    University Hospital Ulm
2021-05-03
May 3, 2021